Kymera Therapeutics, Inc. (KYMR): Shares Outstanding

Annual figures by period end, from SEC filings.

81.32M
As of 2025-12-31
82.79M
As of 2026-06-30
+13.9%
3-year compound annual growth
+12.8%
5-year compound annual growth
2019-12-31: 1.93M2020-12-31: 44.48M2021-12-31: 51.54M2022-12-31: 55.04M2023-12-31: 55.59M2024-12-31: 64.89M2025-12-31: 81.32M81.32M
2019-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3181.32M+25.3%2026-02-26, Balance as of period end
2024-12-3164.89M+16.7%2026-02-26, Balance as of period end
2023-12-3155.59M+1.0%2025-02-27, Balance as of period end
2022-12-3155.04M+6.8%2023-02-23, Balance as of period end
2021-12-3151.54M+15.9%2023-02-23, Balance as of period end
2020-12-3144.48Mn/m2022-02-24, Balance as of period end
2019-12-311.93Mn/a2021-03-11, Balance as of period end